153 related articles for article (PubMed ID: 31505209)
1. Structure-function insights into elusive Mycobacterium tuberculosis protein Rv1916.
Antil M; Sharma J; Brissonnet Y; Choudhary M; Gouin S; Gupta V
Int J Biol Macromol; 2019 Dec; 141():927-936. PubMed ID: 31505209
[TBL] [Abstract][Full Text] [Related]
2. Rv1915 and Rv1916 from Mycobacterium tuberculosis H37Rv form in vitro protein-protein complex.
Antil M; Gupta V
Biochim Biophys Acta Gen Subj; 2022 Jun; 1866(6):130130. PubMed ID: 35307510
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium tuberculosis Rv1916 is an Acetyl-CoA-Binding Protein.
Huang EY; Kwai BXC; Bhusal RP; Bashiri G; Leung IKH
Chembiochem; 2023 Jul; 24(14):e202300162. PubMed ID: 37211532
[TBL] [Abstract][Full Text] [Related]
4. Lessons Learnt and the Way Forward for Drug Development Against Isocitrate Lyase from
Antil M; Gupta V
Protein Pept Lett; 2022; 29(12):1031-1041. PubMed ID: 36201276
[TBL] [Abstract][Full Text] [Related]
5. Lysine succinylation of Mycobacterium tuberculosis isocitrate lyase (ICL) fine-tunes the microbial resistance to antibiotics.
Zhou M; Xie L; Yang Z; Zhou J; Xie J
J Biomol Struct Dyn; 2017 Apr; 35(5):1030-1041. PubMed ID: 27023679
[TBL] [Abstract][Full Text] [Related]
6. Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis.
Gould TA; van de Langemheen H; Muñoz-Elías EJ; McKinney JD; Sacchettini JC
Mol Microbiol; 2006 Aug; 61(4):940-7. PubMed ID: 16879647
[TBL] [Abstract][Full Text] [Related]
7. Potential inhibitors for isocitrate lyase of Mycobacterium tuberculosis and non-M. tuberculosis: a summary.
Lee YV; Wahab HA; Choong YS
Biomed Res Int; 2015; 2015():895453. PubMed ID: 25649791
[TBL] [Abstract][Full Text] [Related]
8. [Clone and expression of isocitrate lyase gene in Mycobacterium tuberculosis H37Rv].
Li DW; Xiao CL; Guan Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):368-71. PubMed ID: 15379258
[TBL] [Abstract][Full Text] [Related]
9. Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis.
Höner Zu Bentrup K; Miczak A; Swenson DL; Russell DG
J Bacteriol; 1999 Dec; 181(23):7161-7. PubMed ID: 10572116
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
11. [Molecular cloning, expression, purification and properties of isocitrate lyase gene from Mycobacterium tuberculosis H37Rv].
Hao F; Pei XY; Zhang XL; Zhang SB; Lai XH; Wang HH
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Dec; 28(12):845-8. PubMed ID: 16409788
[TBL] [Abstract][Full Text] [Related]
12. The Saccharomyces cerevisiae ICL2 gene encodes a mitochondrial 2-methylisocitrate lyase involved in propionyl-coenzyme A metabolism.
Luttik MA; Kötter P; Salomons FA; van der Klei IJ; van Dijken JP; Pronk JT
J Bacteriol; 2000 Dec; 182(24):7007-13. PubMed ID: 11092862
[TBL] [Abstract][Full Text] [Related]
13. Mechanism-based inactivator of isocitrate lyases 1 and 2 from
Pham TV; Murkin AS; Moynihan MM; Harris L; Tyler PC; Shetty N; Sacchettini JC; Huang HL; Meek TD
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7617-7622. PubMed ID: 28679637
[TBL] [Abstract][Full Text] [Related]
14. Demystifying the catalytic pathway of Mycobacterium tuberculosis isocitrate lyase.
Ibeji CU; Salleh NAM; Sum JS; Ch'ng ACW; Lim TS; Choong YS
Sci Rep; 2020 Nov; 10(1):18925. PubMed ID: 33144641
[TBL] [Abstract][Full Text] [Related]
15. Active Site Flexibility of Mycobacterium tuberculosis Isocitrate Lyase in Dimer Form.
Lee YV; Choi SB; Wahab HA; Choong YS
J Chem Inf Model; 2017 Sep; 57(9):2351-2357. PubMed ID: 28820943
[TBL] [Abstract][Full Text] [Related]
16. Insight into the structural flexibility and function of Mycobacterium tuberculosis isocitrate lyase.
Shukla H; Kumar V; Singh AK; Singh N; Kashif M; Siddiqi MI; Yasoda Krishnan M; Sohail Akhtar M
Biochimie; 2015 Mar; 110():73-80. PubMed ID: 25576828
[TBL] [Abstract][Full Text] [Related]
17. Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis.
Nandakumar M; Nathan C; Rhee KY
Nat Commun; 2014 Jun; 5():4306. PubMed ID: 24978671
[TBL] [Abstract][Full Text] [Related]
18. Residues Asn214, Gln211, Glu219 and Gln221 contained in the subfamily 3 catalytic signature of the isocitrate lyase from Pseudomonas aeruginosa are involved in its catalytic and thermal properties.
Campos-Garcia J; Diaz-Perez C; Diaz-Perez AL
World J Microbiol Biotechnol; 2013 Jun; 29(6):991-9. PubMed ID: 23338961
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial antibodies by phage display: Identification of antibody-based inhibitor against mycobacterium tuberculosis isocitrate lyase.
Ch'ng ACW; Schepergerdes L; Choong YS; Hust M; Lim TS
Mol Immunol; 2022 Oct; 150():47-57. PubMed ID: 35987135
[TBL] [Abstract][Full Text] [Related]
20. Solvent isotope-induced equilibrium perturbation for isocitrate lyase.
Quartararo CE; Hadi T; Cahill SM; Blanchard JS
Biochemistry; 2013 Dec; 52(51):9286-93. PubMed ID: 24261638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
